Markov modeling for cost-effectiveness using federated health data network
© The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association..
OBJECTIVE: To introduce 2 R-packages that facilitate conducting health economics research on OMOP-based data networks, aiming to standardize and improve the reproducibility, transparency, and transferability of health economic models.
MATERIALS AND METHODS: We developed the software tools and demonstrated their utility by replicating a UK-based heart failure data analysis across 5 different international databases from Estonia, Spain, Serbia, and the United States.
RESULTS: We examined treatment trajectories of 47 163 patients. The overall incremental cost-effectiveness ratio (ICER) for telemonitoring relative to standard of care was 57 472 €/QALY. Country-specific ICERs were 60 312 €/QALY in Estonia, 58 096 €/QALY in Spain, 40 372 €/QALY in Serbia, and 90 893 €/QALY in the US, which surpassed the established willingness-to-pay thresholds.
DISCUSSION: Currently, the cost-effectiveness analysis lacks standard tools, is performed in ad-hoc manner, and relies heavily on published information that might not be specific for local circumstances. Published results often exhibit a narrow focus, central to a single site, and provide only partial decision criteria, limiting their generalizability and comprehensive utility.
CONCLUSION: We created 2 R-packages to pioneer cost-effectiveness analysis in OMOP CDM data networks. The first manages state definitions and database interaction, while the second focuses on Markov model learning and profile synthesis. We demonstrated their utility in a multisite heart failure study, comparing telemonitoring and standard care, finding telemonitoring not cost-effective.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Journal of the American Medical Informatics Association : JAMIA - 31(2024), 5 vom: 19. Apr., Seite 1093-1101 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haug, Markus [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cost-effectiveness |
|---|
| Anmerkungen: |
Date Completed 22.04.2024 Date Revised 26.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jamia/ocae044 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369618602 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369618602 | ||
| 003 | DE-627 | ||
| 005 | 20240426233904.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240313s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jamia/ocae044 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1388.xml |
| 035 | |a (DE-627)NLM369618602 | ||
| 035 | |a (NLM)38472144 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haug, Markus |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Markov modeling for cost-effectiveness using federated health data network |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.04.2024 | ||
| 500 | |a Date Revised 26.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association. | ||
| 520 | |a OBJECTIVE: To introduce 2 R-packages that facilitate conducting health economics research on OMOP-based data networks, aiming to standardize and improve the reproducibility, transparency, and transferability of health economic models | ||
| 520 | |a MATERIALS AND METHODS: We developed the software tools and demonstrated their utility by replicating a UK-based heart failure data analysis across 5 different international databases from Estonia, Spain, Serbia, and the United States | ||
| 520 | |a RESULTS: We examined treatment trajectories of 47 163 patients. The overall incremental cost-effectiveness ratio (ICER) for telemonitoring relative to standard of care was 57 472 €/QALY. Country-specific ICERs were 60 312 €/QALY in Estonia, 58 096 €/QALY in Spain, 40 372 €/QALY in Serbia, and 90 893 €/QALY in the US, which surpassed the established willingness-to-pay thresholds | ||
| 520 | |a DISCUSSION: Currently, the cost-effectiveness analysis lacks standard tools, is performed in ad-hoc manner, and relies heavily on published information that might not be specific for local circumstances. Published results often exhibit a narrow focus, central to a single site, and provide only partial decision criteria, limiting their generalizability and comprehensive utility | ||
| 520 | |a CONCLUSION: We created 2 R-packages to pioneer cost-effectiveness analysis in OMOP CDM data networks. The first manages state definitions and database interaction, while the second focuses on Markov model learning and profile synthesis. We demonstrated their utility in a multisite heart failure study, comparing telemonitoring and standard care, finding telemonitoring not cost-effective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Markov chains | |
| 650 | 4 | |a OHDSI CDM | |
| 650 | 4 | |a cost-effectiveness | |
| 650 | 4 | |a observational data | |
| 650 | 4 | |a treatment trajectories | |
| 700 | 1 | |a Oja, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a Pajusalu, Maarja |e verfasserin |4 aut | |
| 700 | 1 | |a Mooses, Kerli |e verfasserin |4 aut | |
| 700 | 1 | |a Reisberg, Sulev |e verfasserin |4 aut | |
| 700 | 1 | |a Vilo, Jaak |e verfasserin |4 aut | |
| 700 | 1 | |a Giménez, Antonio Fernández |e verfasserin |4 aut | |
| 700 | 1 | |a Falconer, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Danilović, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Maljkovic, Filip |e verfasserin |4 aut | |
| 700 | 1 | |a Dawoud, Dalia |e verfasserin |4 aut | |
| 700 | 1 | |a Kolde, Raivo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Medical Informatics Association : JAMIA |d 1997 |g 31(2024), 5 vom: 19. Apr., Seite 1093-1101 |w (DE-627)NLM074735535 |x 1527-974X |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2024 |g number:5 |g day:19 |g month:04 |g pages:1093-1101 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jamia/ocae044 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2024 |e 5 |b 19 |c 04 |h 1093-1101 | ||